Skip to content

Author

Tara Sasanka, C

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

The Role of Generative Artificial Intelligence in Modern Business Decision-Making: Applications, Opportunities, and Future Challenges

Generative artificial intelligence (GenAI) has moved rapidly from an experimental technology to a tool actively reshaping how managers gather information, evaluate options, and reach decisions across strategic, operational, and customer-facing business functions. This paper reviews the theoretical and empirical literature on GenAI's role in business decision-making, situating recent large language model (LLM)-based applications within the older organizational decision-making and bounded-rationality literature that predates generative AI by decades. The review synthesizes controlled productivity experiments, large-scale economic-potential estimates, organizational decision-structure theory, and the emerging literature on human-AI complementarity and its limits, including evidence that AI assistance can degrade performance when applied outside a model's effective capability frontier. Particular attention is given to the distinction between GenAI's demonstrated value in well-structured, information-synthesis-heavy decision tasks and its more contested role in tasks requiring novel judgment or accountability. Comparative tables summarize reported productivity effects, business function applications, and organizational barriers to adoption across the reviewed literature. The paper concludes that GenAI's current business value is concentrated in augmenting, rather than automating, decision-making, with the strongest evidence for productivity gains among relatively lower-skilled or lower-performing decision-makers, and identifies the mapping of AI capability boundaries within specific decision domains as the central future research prospect. Generative artificial intelligence (GenAI) has moved rapidly from an experimental technology to a tool actively reshaping how managers gather information, evaluate options, and reach decisions across strategic, operational, and customer-facing business functions. This paper reviews the theoretical and empirical literature on GenAI's role in business decision-making, situating recent large language model (LLM)-based applications within the older organizational decision-making and bounded-rationality literature that predates generative AI by decades. The review synthesizes controlled productivity experiments, large-scale economic-potential estimates, organizational decision-structure theory, and the emerging literature on human-AI complementarity and its limits, including evidence that AI assistance can degrade performance when applied outside a model's effective capability frontier. Particular attention is given to the distinction between GenAI's demonstrated value in well-structured, information-synthesis-heavy decision tasks and its more contested role in tasks requiring novel judgment or accountability. Comparative tables summarize reported productivity effects, business function applications, and organizational barriers to adoption across the reviewed literature. The paper concludes that GenAI's current business value is concentrated in augmenting, rather than automating, decision-making, with the strongest evidence for productivity gains among relatively lower-skilled or lower-performing decision-makers, and identifies the mapping of AI capability boundaries within specific decision domains as the central future research prospect.

Rajidi Rammohan Reddy, Vinodray Thumar, Amar Jyoti Borah et al. · 0 citations
Review Open access Aug 2026

AI-Enabled Smart Healthcare Systems: Innovative Approaches to Disease Prediction, Accurate Diagnosis, and Effective Public Health Management

Artificial intelligence (AI) has moved from a peripheral research interest to a central component of contemporary healthcare delivery, with deep learning systems now matching or exceeding specialist-level performance on discrete diagnostic tasks spanning dermatology, ophthalmology, radiology, and oncology. This paper reviews the technical foundations and applied evidence base for AI-driven smart healthcare systems across three domains: disease prediction from structured and unstructured clinical data, image-based diagnostic classification, and population-level public health management, including the accelerated adoption of AI tools during the COVID-19 pandemic. The review synthesizes landmark diagnostic-performance studies, including dermatologist-level skin cancer classification, diabetic retinopathy detection, pneumonia detection from chest radiographs, and international breast cancer screening evaluation, alongside the clinical machine learning literature addressing implementation, validation, and algorithmic bias. Comparative tables summarize reported diagnostic performance metrics, data modalities, and clinical domains across the reviewed systems. The paper concludes that AI-driven diagnostic systems have achieved genuine, reproducible performance parity with human specialists on narrow, well-defined tasks, while broader clinical deployment remains constrained by validation, generalizability, and algorithmic-bias challenges that the reviewed literature has only begun to resolve, and identifies prospective real-world validation and equity-focused model auditing as the central future research prospects.

Vinit Kumar Ramawat, G.PRABHAKARAN, Pinki Das et al. · 0 citations